Sponsored by:

Nuclear Medicine: Page 51

Lantheus to acquire Progenics
By AuntMinnie.com staff writers
Lantheus Holdings has signed a definitive agreement to acquire oncology firm Progenics Pharmaceuticals in an all-stock transaction.
October 1, 2019
2016 08 24 09 43 13 537 Hands Shaking V3 400
Ga-68 PSMA-11 PET interpretation criteria need work
By Wayne Forrest
Interpretation criteria for gallium-68 (Ga-68) prostate-specific membrane antigen-11 (PSMA-11) PET with CT or MRI for prostate cancer can bolster interreader agreement, but some performance issues remain, according to a study published online September 27 in the Journal of Nuclear Medicine.
October 1, 2019
2019 04 17 20 48 2514 Prostate 3 D 400
Magnetic Insight wins NIH grant
By AuntMinnie.com staff writers
The U.S. National Institutes of Health (NIH) National Cancer Institute has awarded a new research grant to magnetic particle imaging (MPI) technology developer Magnetic Insight.
September 30, 2019
PET/CT beats SPECT for neuroendocrine tumors
By Wayne Forrest
PET/CT performed better than planar scintigraphy or SPECT for determining which patients with neuroendocrine tumors are most likely to benefit from peptide receptor radionuclide therapy, in a study published in the September issue of the Journal of Nuclear Medicine.
September 26, 2019
2019 09 26 17 12 9463 Krenning Scores Net Jnm Hope 20190926175008
FDA approves BWXT's radiopharmaceutical
By AuntMinnie.com staff writers
U.S. government nuclear components supplier BWX Technologies (BWXT) has received approval from the U.S. Food and Drug Administration (FDA) for its abbreviated new drug application for a generic version of indium-111 (In-111) oxyquinoline solution.
September 25, 2019
2016 04 11 16 41 58 174 Approved Stamp 200
USP delays revised radiopharmaceutical standards
By AuntMinnie.com staff writers
The U.S. Pharmacopeial Convention (USP) has postponed until December 1 implementation of several revisions related to the compounding, preparation, and packaging of radiopharmaceuticals.
September 25, 2019
2019 08 15 20 38 9073 Patient Safety 400
Rethinking Ga-68 PSMA-11 PET/CT for bone metastases
By Wayne Forrest
Researchers from the University of California, Los Angeles say it is time to reconsider guidelines in favor of broader use of gallium-68 (Ga-68) prostate-specific membrane antigen-11 (PSMA-11) PET/CT to detect bone metastases in prostate cancer patients, based on findings in their study published September 20 in the Journal of Nuclear Medicine.
September 25, 2019
2018 05 16 22 58 8356 Cancer Cell Target2 400
GE, partners to develop PET tracers
By AuntMinnie.com staff writers
GE Healthcare is teaming up with three companies and one U.S. academic institution to develop a portfolio of PET tracers designed to better predict and monitor patient response to immunotherapies.
September 24, 2019
2018 11 06 23 34 9504 Pet Scan Patient 400
Technologist licensure bill introduced in Pa.
By AuntMinnie.com staff writers
A bill that would require licensure for medical imaging and radiation therapy technologists has been introduced in the Pennsylvania Legislature, according to the Society of Nuclear Medicine and Molecular Imaging (SNMMI).
September 22, 2019
SNMMI sets submission schedule for 2020 meeting
By AuntMinnie.com staff writers
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has adjusted its schedule for abstract submissions for its 2020 annual meeting.
September 17, 2019
2018 05 22 18 57 9927 Snmmi Logo 400
FDA OK's Mayo Clinic cyclotron
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) has approved the opening of a cyclotron facility at the Mayor Clinic in Jacksonville, FL.
September 17, 2019
GE inks deal for imaging antibodies
By AuntMinnie.com staff writers
GE Healthcare has signed a licensing agreement with Australian biotech company AdAlta to develop antibodies for diagnostic imaging.
September 17, 2019
2019 02 05 17 15 4430 Ge Rsna 2018 400
Previous Page
Page 51 of 438
Next Page